Mike Moazami is an accomplished professional with extensive experience in the fields of medicine and chemical biology. As a Postdoctoral Research Associate at the University of Massachusetts Medical School from May 2018 to August 2018, Mike contributed to significant research projects. Mike advanced to a role as Senior Scientist at the University of Oxford from April 2022 to March 2023, followed by a position as Senior Director and Senior Advisor for Nucleic Acid Delivery at Eli Lilly and Company in April 2024. Academically, Mike holds a Bachelor of Medicine and Surgery BM BCh from the University of Oxford (2018-2022), a Doctor of Philosophy - PhD in Chemical Biology from the University of Southampton (2014-2018), and a Master of Chemistry (1st Hons) from the University of Southampton (2011-2014).
This person is not in the org chart
This person is not in any teams
This person is not in any offices